INSM INSMED Inc

  1. Stocks
  2. Healthcare
  3. NASDAQ: INSM

Price (delayed)

$24.24

Market cap

$2.51B

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$3.17

Enterprise value

$2.51B

Highlights
INSM's revenue is up by 11% year-on-year and by 2% since the previous quarter
The company's gross profit rose by 2.9% YoY
The company's quick ratio fell by 16% YoY but it rose by 14% QoQ
INSMED's net income has decreased by 30% YoY and by 9% QoQ
The equity is down by 27% from the previous quarter and by 2.5% YoY
Sector: Healthcare
Industry: Biotechnology
Website: http://www.insmed.com/
Peers: SRPT GILD AERI ALIM

Key stats

What are the main financial stats of INSM
Market
Shares outstanding
103.49M
Market cap
$2.51B
Enterprise value
$2.51B
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
12.39
Price to sales (P/S)
14.89
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
14.94
Earnings
Revenue
$167.77M
EBIT
-$288.05M
EBITDA
-$273.76M
Free cash flow
-$294.44M
Per share
EPS
-$3.17
Free cash flow per share
-$2.86
Book value per share
$1.96
Revenue per share
$1.63
TBVPS
$6.25
Balance sheet
Total assets
$692.39M
Total liabilities
$490.76M
Debt
$407.6M
Equity
$201.64M
Working capital
$419.61M
Liquidity
Debt to equity
2.02
Current ratio
6.16
Quick ratio
5.25
Net debt/EBITDA
0.01
Margins
EBITDA margin
-163.2%
Gross margin
75.4%
Net margin
-190.4%
Operating margin
-172.1%
Efficiency
Return on assets
-39.7%
Return on equity
-103%
Return on invested capital
-55.1%
Return on capital employed
-47.1%
Return on sales
-171.7%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

INSM stock price

How has the INSMED stock price performed over time
Intraday
-3.12%
1 week
-9.08%
1 month
-12.93%
1 year
-7.09%
YTD
-27.19%
QTD
-14.83%

Financial performance

How have INSMED's revenue and profit performed over time
Revenue
$167.77M
Gross profit
$126.49M
Operating income
-$288.71M
Net income
-$319.37M
Gross margin
75.4%
Net margin
-190.4%
INSMED's net income has decreased by 30% YoY and by 9% QoQ
INSMED's operating income has decreased by 28% YoY and by 9% QoQ
The net margin has contracted by 17% YoY and by 6% from the previous quarter
INSMED's operating margin has decreased by 15% YoY and by 7% from the previous quarter

Growth

What is INSMED's growth rate over time

Valuation

What is INSMED stock price valuation
P/E
N/A
P/B
12.39
P/S
14.89
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
14.94
The EPS has declined by 13% year-on-year and by 5% since the previous quarter
The price to book (P/B) is 59% higher than the 5-year quarterly average of 7.8 and 11% higher than the last 4 quarters average of 11.2
The equity is down by 27% from the previous quarter and by 2.5% YoY
INSM's price to sales (P/S) is 22% lower than its last 4 quarters average of 19.1
INSM's revenue is up by 11% year-on-year and by 2% since the previous quarter

Efficiency

How efficient is INSMED business performance
The ROIC has declined by 22% year-on-year and by 7% since the previous quarter
The company's return on assets fell by 20% YoY and by 8% QoQ
The ROS has declined by 19% year-on-year and by 7% since the previous quarter
INSM's ROE is down by 18% YoY and by 9% from the previous quarter

Dividends

What is INSM's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for INSM.

Financial health

How did INSMED financials performed over time
INSM's total assets is 41% higher than its total liabilities
The current ratio has grown by 18% from the previous quarter but it has contracted by 11% YoY
The company's quick ratio fell by 16% YoY but it rose by 14% QoQ
The debt is 102% more than the equity
The debt to equity is up by 37% from the previous quarter and by 4.7% YoY
The equity is down by 27% from the previous quarter and by 2.5% YoY

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.